These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 31348116)
1. Comparing Dried Blood Spots and Plasma Concentrations for Busulfan Therapeutic Drug Monitoring in Children. Dilo A; Daali Y; Desmeules J; Chalandon Y; Uppugunduri CRS; Ansari M Ther Drug Monit; 2020 Feb; 42(1):111-117. PubMed ID: 31348116 [TBL] [Abstract][Full Text] [Related]
2. Dried Plasma Spots and Oral Fluid as Alternative Matrices for Therapeutic Drug Monitoring of Busulfan: Analytical Method Development and Clinical Evaluation. Granzotto FCN; da Silva ACC; Lizot LF; Antunes MV; Linden R Ther Drug Monit; 2021 Jun; 43(3):376-385. PubMed ID: 32960547 [TBL] [Abstract][Full Text] [Related]
3. A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometry. Ansari M; Uppugunduri CR; Déglon J; Théorêt Y; Versace F; Gumy-Pause F; Ozsahin H; Dayer P; Desmules J; Daali Y Rapid Commun Mass Spectrom; 2012 Jun; 26(12):1437-46. PubMed ID: 22592987 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of a dried blood spot method for determination of mycophenolic acid in renal transplant patients. Arpini J; Antunes MV; Pacheco LS; Gnatta D; Rodrigues MF; Keitel E; Linden R Clin Biochem; 2013 Dec; 46(18):1905-8. PubMed ID: 24161478 [TBL] [Abstract][Full Text] [Related]
5. Manual punch versus automated flow-through sample desorption for dried blood spot LC-MS/MS analysis of voriconazole. Martial LC; van den Hombergh E; Tump C; Halmingh O; Burger DM; van Maarseveen EM; Brüggemann RJ; Aarnoutse RE J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1089():16-23. PubMed ID: 29747155 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic drug monitoring of tacrolimus and mycophenolic acid in outpatient renal transplant recipients using a volumetric dried blood spot sampling device. Zwart TC; Gokoel SRM; van der Boog PJM; de Fijter JW; Kweekel DM; Swen JJ; Guchelaar HJ; Moes DJAR Br J Clin Pharmacol; 2018 Dec; 84(12):2889-2902. PubMed ID: 30176064 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic Drug Monitoring of Busulfan for the Management of Pediatric Patients: Cross-Validation of Methods and Long-Term Performance. Choong E; Uppugunduri CRS; Marino D; Kuntzinger M; Doffey-Lazeyras F; Lo Piccolo R; Chalandon Y; Peters C; Daali Y; Ansari M Ther Drug Monit; 2018 Feb; 40(1):84-92. PubMed ID: 29189665 [TBL] [Abstract][Full Text] [Related]
8. Dried blood spot analysis for therapeutic drug monitoring of pazopanib. de Wit D; den Hartigh J; Gelderblom H; Qian Y; den Hollander M; Verheul H; Guchelaar HJ; van Erp NP J Clin Pharmacol; 2015 Dec; 55(12):1344-50. PubMed ID: 26032288 [TBL] [Abstract][Full Text] [Related]
10. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Antipsychotics: Drawbacks of Its Clinical Application. Kloosterboer SM; de Winter BCM; Bahmany S; Al-Hassany L; Dekker A; Dieleman GC; van Gelder T; Dierckx B; Koch BCP Ther Drug Monit; 2018 Jun; 40(3):344-350. PubMed ID: 29505492 [TBL] [Abstract][Full Text] [Related]
11. Determination of clozapine and norclozapine in dried plasma spot and dried blood spot by liquid chromatography-tandem mass spectrometry. Carniel E; Dos Santos KA; de Andrade de Lima L; Kohlrausch R; Linden R; Antunes MV J Pharm Biomed Anal; 2022 Feb; 210():114591. PubMed ID: 35033943 [TBL] [Abstract][Full Text] [Related]
12. Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Vu DH; Bolhuis MS; Koster RA; Greijdanus B; de Lange WC; van Altena R; Brouwers JR; Uges DR; Alffenaar JW Antimicrob Agents Chemother; 2012 Nov; 56(11):5758-63. PubMed ID: 22926568 [TBL] [Abstract][Full Text] [Related]
13. Dried Blood Spot Sampling for Tacrolimus and Mycophenolic Acid in Children: Analytical and Clinical Validation. Martial LC; Hoogtanders KEJ; Schreuder MF; Cornelissen EA; van der Heijden J; Joore MA; Van Maarseveen EM; Burger DM; Croes S; Brüggemann RJM; Aarnoutse RE Ther Drug Monit; 2017 Aug; 39(4):412-421. PubMed ID: 28700522 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of dried blood spot sampling for pharmacokinetic research and therapeutic drug monitoring of anti-tuberculosis drugs in children. Martial LC; Kerkhoff J; Martinez N; Rodríguez M; Coronel R; Molinas G; Roman M; Gomez R; Aguirre S; Jongedijk E; Huisman J; Touw DJ; Pérez D; Chaparro G; Gonzalez F; Aarnoutse RE; Alffenaar JW; Magis-Escurra C Int J Antimicrob Agents; 2018 Jul; 52(1):109-113. PubMed ID: 29751121 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic drug monitoring of valproic acid using a dried plasma spot sampling device. Li Y; Jiang Y; Cao H; Lin H; Ren W; Huang J; Zhang J J Mass Spectrom; 2021 Apr; 56(4):e4603. PubMed ID: 33729629 [TBL] [Abstract][Full Text] [Related]
16. Analytical and clinical validation of an LC-MS/MS method for carbamazepine, lamotrigine and levetiracetam in dried blood spots. Besten-Bertholee DD; Wegner I; Touw DJ; Ter Horst PGJ Eur J Hosp Pharm; 2024 Aug; 31(5):450-454. PubMed ID: 36894298 [TBL] [Abstract][Full Text] [Related]
17. Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer. Willemsen AECAB; Knapen LM; de Beer YM; Brüggemann RJM; Croes S; van Herpen CML; van Erp NP Eur J Clin Pharmacol; 2018 Apr; 74(4):465-471. PubMed ID: 29222715 [TBL] [Abstract][Full Text] [Related]
18. Dried Blood Spot Analysis for Therapeutic Drug Monitoring of Clozapine. Geers LM; Cohen D; Wehkamp LM; van Hateren K; Koster RA; Fedorenko OY; Semke AV; Bokhan N; Ivanova SA; Kosterink JGW; Loonen AJM; Touw DJ J Clin Psychiatry; 2017; 78(9):e1211-e1218. PubMed ID: 29068609 [TBL] [Abstract][Full Text] [Related]
19. Determination of lithium in dried blood spots and dried plasma spots by graphite furnace atomic absorption spectrometry: Method development, validation and clinical application. Manfro ID; Tegner M; Krutzmann ME; Artmann ADC; Brandeburski MR; Peteffi GP; Linden R; Antunes MV Talanta; 2020 Aug; 216():120907. PubMed ID: 32456895 [TBL] [Abstract][Full Text] [Related]
20. Application of non-contact hematocrit prediction technologies to overcome hematocrit effects on immunosuppressant quantification from dried blood spots. Deprez S; Heughebaert L; Boffel L; Stove CP Talanta; 2023 Mar; 254():124111. PubMed ID: 36462285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]